Key result
Higher circulating T lymphocytes 24 hours post-PCI link to smaller STEMI infarct size.
Why the study?
An in-depth characterization of adaptive immune cell dynamics and their potential role in STEMI after reperfusion remains elusive.
Are changes in circulating T lymphocyte subsets following ischemia-reperfusion associated with infarct size in STEMI patients?
Observational (n=116)
Are changes in circulating T lymphocyte subsets following ischemia-reperfusion associated with infarct size in STEMI patients?
Ischemia-reperfusion induces a sharp drop in circulating T lymphocytes, which inversely correlates with infarct size, suggesting a role for adaptive immunity in myocardial infarction.
Post-PCI T lymphocyte counts may refine STEMI prognosis; hypothesis-generating for immunomodulatory strategies.
ST-segment elevation myocardial infarction (STEMI) is the most severe outcome of coronary artery disease. Despite rapid reperfusion of the artery, acute irrigation of the cardiac tissue is associated with increased inflammation. While innate immune response in STEMI is well described, an in-depth characterization of adaptive immune cell dynamics and their potential role remains elusive. We performed a translational study using a controlled porcine reperfusion model of STEMI and the analysis of lymphocyte subsets in 116 STEMI patients undergoing percutaneous coronary intervention (PCI). In the animal model, a sharp drop in circulating T lymphocytes occurred within the first hours after reperfusion. Notably, increased apoptosis of circulating lymphocytes and infiltration of proinflammatory Th1 lymphocytes in the heart were observed 48 h after reperfusion. Similarly, in STEMI patients, a sharp drop in circulating T lymphocyte subsets occurred within the first 24 h post-PCI. A cardiac magnetic resonance (CMR) evaluation of these patients revealed an inverse association between 24 h circulating T lymphocyte numbers and infarction size at 1-week and 6-month post-PCI. Our translational approach revealed striking changes in the circulating and tissue-infiltrating T lymphocyte repertoire in response to ischemia-reperfusion. These findings may help in developing new diagnostic and therapeutic approaches for coronary diseases.
No takes yet. Share an insight, caveat, or question.
Forteza et al. (2018) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=116). Circulating T lymphocyte numbers at 24 h post-PCI was evaluated on Infarction size at 1-week and 6-month post-PCI. Circulating T lymphocyte numbers at 24 hours post-PCI were inversely associated with infarction size at 1-week and 6-month follow-up in STEMI patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: